25-hydroxy-vitamin D concentration is not affected by severe or non-severe pneumonia, or inflammation, in young children

Nutrients

Volumn 9, Issue 1, 2017, Pages

  Haugen, Johanne ^a,b   Chandyo, Ram K ^c   Ulak, Manjeswori ^d   Mathisen, Maria ^e   Basnet, Sudha ^d   Brokstad, Karl A ^b   Valentiner Branth, Palle ^f   Shrestha, Prakash S ^d   Strand, Tor A ^a,b  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c KATHMANDU MEDICAL COLLEGE   (Nepal)

^d TRIBHUVAN UNIVERSITY   (Nepal)

^e UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^f STATENS SERUM INSTITUT   (Denmark)

Author keywords

Acute lower respiratory tract infection; Children; Inflammation; Nepal; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR; VASCULOTROPIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ARTICLE; BLOOD LEVEL; CHILD; CYTOMETRY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOASSAY; INFLAMMATION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PROTEIN BINDING; RANDOMIZED CONTROLLED TRIAL (TOPIC); ACUTE DISEASE; ANALOGS AND DERIVATIVES; BLOOD; FOLLOW UP; INFANT; NEPAL; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; STATISTICAL MODEL;

ACUTE DISEASE; BIOMARKERS; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFLAMMATION; LINEAR MODELS; MALE; NEPAL; PNEUMONIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY TRACT INFECTIONS; VITAMIN D;

EID: 85010402674     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9010052     Document Type: Article

References (35)

1. Laaksi, I.; Ruohola, J.P.; Tuohimaa, P.; Auvinen, A.; Haataja, R.; Pihlajamaki, H.; Ylikomi, T. An association of serum vitamin D concentrations <40 nmol/L with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr. 2007, 86, 714-717.
2. Karatekin, G.; Kaya, A.; Salihoglu, O.; Balci, H.; Nuhoglu, A. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur. J. Clin. Nutr. 2009, 63, 473-477.
3. McNally, J.D.; Leis, K.; Matheson, L.A.; Karuananyake, C.; Sankaran, K.; Rosenberg, A.M. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr. Pulmonol. 2009, 44, 981-988.
4. Wayse, V.; Yousafzai, A.; Mogale, K.; Filteau, S. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 years. Eur. J. Clin. Nutr. 2004, 58, 563-567.
5. Kamen, D.L.; Tangpricha, V. Vitamin D and molecular actions on the immune system: Modulation of innate and autoimmunity. J. Mol. Med. (Berl) 2010, 88, 441-450.
6. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281.
7. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311, 1770-1773.
8. Gombart, A.F.; Borregaard, N.; Koeffler, H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19, 1067-1077.
9. Wang, T.T.; Nestel, F.P.; Bourdeau, V.; Nagai, Y.; Wang, Q.; Liao, J.; Tavera-Mendoza, L.; Lin, R.; Hanrahan, J.W.; Mader, S. et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173, 2909-2912.
10. Bergman, P.; Lindh, A.U.; Bjorkhem-Bergman, L.; Lindh, J.D. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS ONE 2013, 8, e65835.
11. Xiao, L.; Xing, C.; Yang, Z.; Xu, S.; Wang, M.; Du, H.; Liu, K.; Huang, Z. Vitamin D supplementation for the prevention of childhood acute respiratory infections: A systematic review of randomised controlled trials. Br. J. Nutr. 2015, 114, 1026-1034.
12. Jolliffe, D.A.; Griffiths, C.J.; Martineau, A.R. Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies. J. Steroid Biochem. Mol. Biol. 2013, 136, 321-329.
13. Waldron, J.L.; Ashby, H.L.; Cornes, M.P.; Bechervaise, J.; Razavi, C.; Thomas, O.L.; Chugh, S.; Deshpande, S.; Ford, C.; Gama, R. Vitamin D: A negative acute phase reactant. J. Clin. Pathol. 2013, 66, 620-622.
14. Reid, D.; Toole, B.J.; Knox, S.; Talwar, D.; Harten, J.; O’Reilly, D.S.; Blackwell, S.; Kinsella, J.; McMillan, D.C.; Wallace, A.M. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am. J. Clin. Nutr. 2011, 93, 1006-1011.
15. Bang, U.C.; Novovic, S.; Andersen, A.M.; Fenger, M.; Hansen, M.B.; Jensen, J.E. Variations in serum 25-hydroxyvitamin D during acute pancreatitis: An exploratory longitudinal study. Endocr. Res. 2011, 36, 135-141.
16. Silva, M.C.; Furlanetto, T.W. Does serum 25-hydroxyvitamin D decrease during acute-phase response? A systematic review. Nutr. Res. 2015, 35, 91-96.
17. Newens, K.; Filteau, S.; Tomkins, A. Plasma 25-hydroxyvitamin D does not vary over the course of a malarial infection. Trans. R. Soc. Trop. Med. Hyg. 2006, 100, 41-44.
18. Binfield, A.; Aird, C.; Murdoch, D.R.; Elder, P.; Walls, T. Are vitamin D levels affected by acute bacterial infections in children? J. Paediatr. Child Health 2014, 50, 643-646.
19. Valentiner-Branth, P.; Shrestha, P.S.; Chandyo, R.K.; Mathisen, M.; Basnet, S.; Bhandari, N.; Adhikari, R.K.; Sommerfelt, H.; Strand, T.A. A randomized controlled trial of the effect of zinc as adjuvant therapy in children 2-35 months of age with severe or nonsevere pneumonia in Bhaktapur, Nepal. Am. J. Clin. Nutr. 2010, 91, 1667-1674.
20. World Health Organization. Integrated Management of Childhood Illness; World Health Organization: Geneva, Switzerland, 2002.
21. Haugen, J.; Chandyo, R.K.; Brokstad, K.A.; Mathisen, M.; Ulak, M.; Basnet, S.; Valentiner-Branth, P.; Strand, T.A. Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia. PLoS ONE 2015, 10, e0138978.
22. Chandyo, R.K.; Shrestha, P.S.; Valentiner-Branth, P.; Mathisen, M.; Basnet, S.; Ulak, M.; Adhikari, R.K.; Sommerfelt, H.; Strand, T.A. Two weeks of zinc administration to Nepalese children with pneumonia does not reduce the incidence of pneumonia or diarrhea during the next six months. J. Nutr. 2010, 140, 1677-1682.
23. BioRad Laboratories. Bio-Plex Pro™ Cytokine, Chemokine, and Growth Factor Assays Instruction Manual; BioRad Inc. Life Science Research: Hercules, CA, USA, 2016.
24. Wood, S. Modelling and Smoothing Parameter Estimation with Multiple Quadratic Penalties. J. R. Stat. Soc. B 2000, 62, 413-428.
25. Hosmer, D.W.; Lemeshow, S. Applied Logistic Regression, 2nd ed.; John Wiley & Sons Inc.: New York, NY, USA, 2000.
26. Adhikari, K.R. Estimation of Global Solar Radiation for Four Selected Sites in Nepal Using Sunshine Hours, Temperature and Relative Humidity. J. Power Energy Eng. 2013, 1, 1-9.
27. Ministry of Health and Population (MOHP); New ERA; ICF International Inc. Nepal Demographic and Health Survey 2011. Available online: http://reliefweb.int/sites/reliefweb.int/files/resources/nepal%20demographic%20and%20health%20survey%202011.pdf (accessed on 9 January 2017).
28. Avagyan, D.; Neupane, S.P.; Gundersen, T.E.; Madar, A.A. Vitamin D status in pre-school children in rural Nepal. Public Health Nutr. 2015, 1-7.
29. Hollis, B.W.; Wagner, C.L.; Howard, C.R.; Ebeling, M.; Shary, J.R.; Smith, P.G.; Taylor, S.N.; Morella, K.; Lawrence, R.A.; Hulsey, T.C. Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial. Pediatrics 2015, 136, 625-634.
30. Hollis, B.W.; Wagner, C.L. Vitamin D requirements during lactation: High-dose maternal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am. J. Clin. Nutr. 2004, 80 (Suppl 6), 1752S-1758S.
31. Wall, C.R.; Stewart, A.W.; Camargo, C.A., Jr.; Scragg, R.; Mitchell, E.A.; Ekeroma, A.; Crane, J.; Milne, T.; Rowden, J.; Horst, R. et al. Vitamin D activity of breast milk in women randomly assigned to vitamin D3 supplementation during pregnancy. Am. J. Clin. Nutr. 2016, 103, 382-388.
32. Greer, F.R.; Hollis, B.W.; Cripps, D.J.; Tsang, R.C. Effects of maternal ultraviolet B irradiation on vitamin D content of human milk. J. Pediatr. 1984, 105, 431-433.
33. Roche Diagnostics International Ltd. Elecsys Vitamin D total assay. Electro-chemiluminescence Binding Assay (ECLIA) for the in Vitro Determination of Total 25-hydroxyvitamin D. Roche Diagnostics International Ltd.: Rotkreuz, Switzerland, 2012.
34. Bailey, D.; Veljkovic, K.; Yazdanpanah, M.; Adeli, K. Analytical measurement and clinical relevance of vitamin D(3) C3-epimer. Clin. Biochem. 2013, 46, 190-196.
35. Singh, R.J.; Taylor, R.L.; Reddy, G.S.; Grebe, S.K. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J. Clin. Endocrinol. Metab. 2006, 91, 3055-3061.